Trexquant Investment LP

Position in RLAY — Relay Therapeutics, Inc.

CIK 1633445 STAMFORD, CT

Position in RLAY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,844,238

+$1,906,471 QoQ

Shares Held

152,017

+61.3% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#94

of 256 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. RLAY ranks #58 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	REGN	Regeneron Pharmaceuticals, Inc.	41,839	$26,088,290
3	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
4	AXSM	Axsome Therapeutics, Inc.	83,679	$20,482,108
5	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
6	INSM	INSMED Inc	156,553	$16,691,680
7	SRRK	Scholar Rock Holding Corp	275,712	$15,164,160
8	EXEL	Exelixis, Inc.	275,209	$14,974,121

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,844,238	152,017	+61.3%	Shares	Sole	2026-08-14
2026-03-31	$937,767	94,248	-80.0%	Shares	Sole	2026-05-15
2025-12-31	$3,993,500	472,045	+45.5%	Shares	Sole	2026-02-17
2025-03-31	$850,108	324,469	-66.8%	Shares	Sole	2025-05-14
2024-12-31	$4,029,924	978,137	+137.5%	Shares	Sole	2025-02-12
2024-09-30	$2,915,982	411,862	+123.1%	Shares	Sole	2024-11-12
2024-06-30	$1,203,728	184,621	+43.2%	Shares	Sole	2024-08-13
2023-12-31	$1,419,078	128,890	-35.1%	Shares	Sole	2024-02-09
2023-09-30	$1,670,823	198,671	+926.5%	Shares	Sole	2023-11-13
2023-06-30	$243,086	19,354	-10.7%	Shares	Sole	2023-08-11
2022-12-31	$323,958	21,684	-88.2%	Shares	Sole	2023-02-13
2022-06-30	$3,070,057	183,287	+2060.9%	Shares	Sole	2022-08-11
2021-03-31	$293,222	8,482	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.